Sacubitril–Valsartan
Advertisement
LIFE: Sacubitril-Valsartan Safe in Patients with Advanced HF, But Without Significant Effect on NT-proBNP
Mark Belkin, MDACC 2021 Conference | April 19, 2023
Editor's Note: This dispatch from ACC.21 was written by Mark Belkin, MD, a cardiology fellow at the University of ...
Read More
Cardio Round-up: TAVR in Rural Areas; Smoking and COVID Risk; and More
DocWire News EditorsInterventional Cardiology | May 2, 2023
Common CVD Risk Factor Also Linked with Increased COVID-19 Risk ...
Read More
PARAGON-HF Misses Primary Endpoint: Novartis
DocWire News EditorsHeart Failure | May 2, 2023
The PARAGON-HF trial, evaluating the safety and efficacy of sacubitril/valsartan versus valsartan alone in patients with ...
Read More
PIONEER-HF: Sacubitril-Valsartan Stabilizes Acute Decompensated HF, Reduces Rehospitalization
DocWire News EditorsAHA Scientific Sessions 2018 | April 10, 2023
In patients with hemodynamically stabilized acute heart failure with reduced ejection fraction (HFrEF), a combination ...
Read More
Advertisement
Advertisement
Advertisement
Latest News

New Insights on 68Ga PET/CT for Staging and Surveillance of GEP-NETs

February 26, 2025

FDA Grants Fast Track Designation to IBI363 for Squamous NSCLC

February 25, 2025

Revolutionizing Sleep Apnea Diagnostics With Home Sleep Testing Solutions

February 25, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |